101 DEGREES FAHRENHEIT,HODGKIN'S LYMPHOMA,HUMORAL HYPERCALCEMIA OF MALIGNANCY,HYPERCALCEMIA,HYPERCALCEMIA ASSOCIATED WITH METASTATIC BREAST CARCINOMA,HYPERCALCEMIA ASSOCIATED WITH NEOPLASM,HYPERCALCEMIA ASSOCIATED WITH SARCOIDOSIS,HYPERCOAGULABILITY STATES,HYPERKALEMIA,HYPERSENSITIVITY ANGIITIS,HYPERSENSITIVITY PNEUMONITIS,HYPERTHYROIDISM,HYPERURICEMIA,HYPOALBUMINEMIA,HYPOGAMMAGLOBULINEMIA,HYPOGLYCEMIC DISORDER,HYPONATREMIA,HYPOPLASTIC ANEMIA,HYPOXIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNOCOMPROMISED PATIENTS,IMMUNOSUPPRESSION,INCOMPLETE TESTICULAR DEVELOPMENT,INCREASED CARDIOVASCULAR EVENT RISK,INCREASED CREATINE PHOSPHOKINASE,INCREASED RISK OF BLEEDING,INFECTED ATOPIC DERMATITIS,INFECTION,INFLAMMATORY BOWEL DISEASE,INTERSTITIAL LUNG DISEASE,INTRINSIC ASTHMA,LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION,LEFT VENTRICULAR FAILURE,LEUKEMIA,LEUKOCYTOSIS,LOWER RESPIRATORY INFECTIONS,LUNG TRANSPLANTATION,LUPUS ANTICOAGULANT DISORDER,LYMPHADENOPATHY,LYMPHOID LEUKEMIA,MALABSORPTION STATES,MALE HYPOGONADISM,MALIGNANCY,MALIGNANT BONE DISEASE,MALIGNANT BRAIN NEOPLASM,MALIGNANT LYMPHOMA,MALIGNANT NEOPLASM OF BONE MARROW,MALIGNANT NEOPLASM OF SKIN,MALIGNANT NEOPLASM OF URINARY SYSTEM,MONOCLONAL GAMMOPATHY,MULTIPLE MYELOMA,MULTIPLE SCLEROSIS,MUSCLE WEAKNESS,MYASTHENIA GRAVIS,MYCOSIS FUNGOIDES,MYELODYSPLASTIC SYNDROME,MYOCARDITIS,MYOPATHY,MYOPATHY WITH CK ELEVATION,MYOSITIS,NASAL CONGESTION,NASAL POLYP,NECROTIZING ENTEROCOLITIS,NEOPLASM,NEPHROTIC SYNDROME,NEUROMUSCULAR BLOCKADE,NEUROMUSCULAR DISEASE,NEUROMUSCULAR TRANSMISSION DEFICIENCY,NEUROPATHY,NON-HODGKIN'S LYMPHOMA,NUTRITIONAL DISORDER,OBSTRUCTIVE BRONCHIOLITIS,OBSTRUCTIVE PULMONARY DISEASE,OCCLUSIVE VASCULAR DISEASE,OCULAR DISORDERS,OCULAR INFLAMMATION,OLIGURIA,OPTIC NEURITIS,ORAPRED,ORGAN TRANSPLANT WITH IMMUNOSUPPRESSIVE THERAPY,ORGANIC CARDIAC DISEASE,OSTEOLYTIC NEOPLASM,OTITIS EXTERNA ECZEMA,PARASITIC INFECTION,PEMPHIGUS,PERICARDIAL EFFUSION,PERICARDITIS,PERIPHERAL MOTOR NEUROPATHY,PERIPHERAL NEUROPATHY,PERIPHERAL VASCULAR DISEASE,PERNICIOUS ANEMIA,PHLEBITIS,PLAQUE PSORIASIS,PNEUMOCYSTIS CARINII PNEUMONIA,PNEUMONIA,PRE-EXISTING FLUID RETENTION,PREDISPOSITION TO GI HEMORRHAGE,PREDISPOSITION TO THROMBOSIS,PREDNISOLONE SOD PHOSPHATE,PRIMARY ADRENOCORTICAL INSUFFICIENCY,PROCTITIS,PROSTATIC CARCINOMA,PROTEINURIA,PROTOZOAL INFECTION,PRURITUS OF SKIN,PSORIASIS,PULMONARY CONGESTION,PULMONARY DISEASE,PULMONARY EDEMA,PULMONARY EMPHYSEMA,PULMONARY FIBROSIS,PULMONARY INFILTRATES,PURPURA,PUSTULAR PSORIASIS,RAW SKIN,RENAL DISEASE,RENAL DISEASE WITH MILD TO MODERATE RENAL FUNCTION IMPAIRMENT,RENAL FAILURE,RENAL TRANSPLANT,REPRODUCTIVE SYSTEM DISORDER,RHEUMATOID ARTHRITIS,SALIVARY SECRETION DISORDER,SARCOIDOSIS,SECONDARY MALIGNANT NEOPLASM OF BONE MARROW,SECONDARY MALIGNANT NEOPLASM OF LYMPH NODES,SEPTIC THROMBOPHLEBITIS,SEVERE ADRENAL INSUFFICIENCY,SEVERE ALLERGIC RHINITIS,SEVERE ANEMIA,SEVERE BONE MARROW DEPRESSION,SEVERE CARDIAC DISEASE,SEVERE CARDIOVASCULAR DISEASE,SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SEVERE COAGULATION DEFECTS,SEVERE CROHN'S DISEASE,SEVERE DIARRHEA,SEVERE HYPOXEMIA,SEVERE INFECTION,SEVERE RENAL DISEASE,SEVERE THROMBOCYTOPENIA,SEVERE ULCERATIVE COLITIS,SHIONOGI PHARMA,SHOULDER TENDONITIS,SIGNIFICANT BLEEDING,SJOGREN'S SYNDROME,SKIN AND SKIN STRUCTURE NEOPLASM,SKIN INFLAMMATION,SKIN IRRITATION,SKIN PHOTOSENSITIVITY,SKIN RASH,SKIN ULCER,STATUS ASTHMATICUS,STEATORRHEA,STEVENS-JOHNSON SYNDROME,SUBACUTE INFECTIVE ENDOCARDITIS,SUPERFICIAL SKIN ULCER,SURGICAL OR OTHER PROCEDURE,SYSTEMIC LUPUS ERYTHEMATOSUS,TEAR FILM INSUFFICIENCY,TENDONITIS,THROMBOCYTOPENIC DISORDER,THROMBOPHLEBITIS,THROMBOPHLEBITIS MIGRANS,THROMBOSIS IN HEPARIN INDUCED THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THYROIDITIS,TOXIC EPIDERMAL NECROLYSIS,TRANSPLANTATION PROCEDURE,ULCERATION OF COLON,ULCERATION OF INTESTINE,ULCERATIVE COLITIS,ULCERATIVE PROCTITIS,UNCONTROLLED BACTERIAL INFECTIONS,UNCONTROLLED COAGULATION DEFECTS,UNTREATED BACTERIAL INFECTION,UNTREATED FUNGAL INFECTION,URTICARIA,UVEITIS,VASCULITIS,VERTEBRAL METASTASES,VITILIGO,WHEEZING'/>
Orapred
ORAPRED (prednisolone sod phosphate)
ORAPRED (prednisolone sod phosphate)
Contraindicated
- None
Severe
- None
Moderate
Contraindicated
- None
Severe
- None
Moderate
ORAPRED (prednisolone sod phosphate)
More Frequent
Severe
- None
Less Severe
- None
Less Frequent
Severe
- None
Less Severe
- None
Rare / Very Rare
Severe
Less Severe
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
General |
Excretion Potential |
Effect on Infant |
Notes |
|
|
|
None |
Precaution Exists
None
General |
Excretion Potential |
Effect on Infant |
Notes |
|
|
|
None |
No Known Risk
None
General |
Excretion Potential |
Effect on Infant |
Notes |
|
|
|
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
Formulary Reference Tool
Please wait while the formulary information is being retrieved.